Termination for IP Challenge. ▇▇▇▇▇ will have the right to terminate this Agreement in full upon written notice to Clovis in the event that Clovis or any of its Affiliates, Sublicensees or Distributors directly or indirectly challenges in a legal or administrative proceeding the patentability, enforceability or validity of any Avila Patents; provided that ▇▇▇▇▇ will not have the right to terminate this Agreement under this Section 12.2(b) for any such challenge by any Sublicensee or Distributor if such challenge is dismissed within thirty (30) days of ▇▇▇▇▇’▇ notice to Clovis under this Section 12.2(b) and not thereafter continued.
Appears in 2 contracts
Sources: Strategic License Agreement (Clovis Oncology, Inc.), Strategic License Agreement (Clovis Oncology, Inc.)